There has been major growth in understanding immune suppression
mechanisms and its relationship to cancer progression and therapy.
This book highlights emerging new principles of immune suppression
that drive cancer, and it offers radically new ideas about how
therapy can be improved by attacking these principles. Following
work that firmly establishes immune escape as an essential trait of
cancer, recent studies have now defined specific mechanisms of
tumor immune suppression. It also demonstrates how attacking tumors
with molecular targeted therapeutics or traditional
chemotherapeutic drugs can produce potent anti-tumor effects in
preclinical models. This book provides basic, translational, and
clinical cancer researchers with an indispensable overview of
immune escape as a critical trait in cancer and how applying
specific combinations of immunotherapy and chemotherapy to attack
this trait may radically improve the treatment of advanced
disease.
Offers a synthesis of concepts that are useful to cancer
immunologists and pharmacologists, who tend to work in disparate
fields with little cross-communication Drs. Prendergast and Jaffee
are internationally recognized leaders in cancer biology and
immunology who have created a unique synthesis of fundamental and
applied concepts in this important new area of cancer research
Summarizes the latest insights into how immune escape defines an
essential trait of cancer Includes numerous illustrations,
including how molecular-targeted therapeutic drugs or traditional
chemotherapy can be combined with immunotherapy to improve
anti-tumor efficacy and how reversing immune suppression by the
tumor can cause tumor regression
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!